First Time Loading...

Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA

Watchlist Manager
Kiniksa Pharmaceuticals Ltd Logo
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
Watchlist
Price: 20.08 USD 3.61% Market Closed
Updated: May 4, 2024

Kiniksa Pharmaceuticals Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kiniksa Pharmaceuticals Ltd
Cash from Financing Activities Peer Comparison

Comparables:

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
Cash from Financing Activities
$1.5m
CAGR 3-Years
-81%
CAGR 5-Years
-64%
CAGR 10-Years
N/A

See Also

What is Kiniksa Pharmaceuticals Ltd's Cash from Financing Activities?
Cash from Financing Activities
1.5m USD

Based on the financial report for Mar 31, 2024, Kiniksa Pharmaceuticals Ltd's Cash from Financing Activities amounts to 1.5m USD.

What is Kiniksa Pharmaceuticals Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-64%

Over the last year, the Cash from Financing Activities growth was -32%. The average annual Cash from Financing Activities growth rates for Kiniksa Pharmaceuticals Ltd have been -81% over the past three years , -64% over the past five years .